FDA-Approved Peptides: The Complete List and What They Treat (2026)

Peptide therapy is everywhere right now, from wellness clinics to social media ads promising faster muscle recovery and slower aging. But most of what gets called “peptide therapy” online has nothing to do with FDA-approved peptides. This article sorts out which peptides the FDA has actually approved as medicines, which ones are still under review, and which ones are sold without any FDA backing at all.

Key Takeaways

• FDA-approved peptides include well-known drugs like semaglutide, tirzepatide, insulin, and teriparatide, each backed by full clinical trials.
• “FDA-approved” is different from being allowed in pharmacy compounding, which is different again from being sold as an unregulated research chemical.
• Popular wellness peptides like BPC-157, TB-500, and CJC-1295 are not FDA-approved drugs.
• In July 2026, an FDA advisory committee recommended adding six peptides to the compounding list, but that recommendation has not yet become final FDA policy.
• Evidence quality varies widely. Always check whether a claim is based on human trials, animal studies, or anecdotes.
• Talk to a licensed healthcare provider before starting any peptide, approved or otherwise.

By the end, you’ll know the real regulatory status of the peptides you keep hearing about, what solid evidence supports them, and where the risks are.

What Are Peptides, Exactly?

Peptides are short chains of amino acids, the building blocks that also make up proteins. Your body makes thousands of peptides naturally. They act like messengers, telling cells when to grow, repair tissue, or release hormones.

Because peptides already “speak the body’s language,” drug companies have used them to build medicines for decades. Insulin, the hormone people with diabetes rely on, is a peptide. So are several major weight-loss drugs on the market today.

However, “peptide” is a broad category. It includes decades-old FDA-approved drugs and also unproven powders sold online labeled “for research use only.” The name alone tells you nothing about safety or legality.

What Does “FDA-Approved” Actually Mean for a Peptide?

This is the part most articles on this topic get wrong, so it’s worth explaining clearly.

An FDA-approved peptide has gone through a specific process:

• Laboratory and animal testing to check for basic safety
• Phase 1 through Phase 3 human clinical trials
• A formal application (a New Drug Application or Biologics License Application) reviewed by FDA scientists
• Approved labeling that spells out exact doses, risks, and approved uses
• Ongoing manufacturing quality checks after approval

A peptide that has cleared all of this can be legally prescribed and sold as a finished drug, such as Ozempic or Forteo.

That’s very different from a peptide being allowed into compounding. Compounding pharmacies mix custom medications for individual patients, and under certain rules, they can use non-approved bulk substances. The FDA sorts these substances into Category 1 (under review, no major safety flag yet) and Category 2 (identified safety concerns, generally off-limits). Being allowed in compounding is not the same as FDA drug approval. We’ll come back to this distinction, because it’s central to the current news around peptides like BPC-157.

Top FDA-Approved Peptides You Should Know

Here’s a quick-reference look at some of the best-established, FDA-approved peptide medications. This is not a complete list of every approved peptide, but it covers the ones people ask about most.

Diabetes and Weight Management

This is where most people first hear the word “peptide” today. Semaglutide and tirzepatide belong to a class called GLP-1 receptor agonists (tirzepatide also acts on a second receptor, GIP). They slow digestion and reduce appetite, which is why they help with both blood sugar control and weight loss.

These drugs have some of the strongest clinical trial evidence of any peptide class. That said, they also carry real, documented side effects, including nausea, vomiting, and rare but serious risks like pancreatitis. They require a prescription and medical supervision.

Bone and Hormone Conditions

Teriparatide and calcitonin help build bone density in people with osteoporosis. Leuprolide and similar drugs temporarily lower sex hormone levels, which is useful in prostate cancer and endometriosis. These peptides have been on the market for decades and have long safety track records.

Growth, Metabolic, and Rare Conditions

Tesamorelin treats a specific fat-redistribution problem linked to HIV treatment. Octreotide and related drugs manage rare hormone-secreting tumors. These are targeted treatments for specific diagnoses, not general wellness products.

Everyday Uses You Might Not Realize Are Peptides

Desmopressin and oxytocin are peptides used in labor and delivery and for certain hormone disorders. Linaclotide treats chronic constipation. These are common prescriptions that rarely get labeled “peptide therapy” in marketing, even though that’s exactly what they are.

Popular Peptides That Are NOT FDA-Approved

This is the list that causes the most confusion, because these names show up constantly in fitness and longevity content:

• BPC-157 – marketed for gut and tendon healing
• TB-500 (a fragment of thymosin beta-4) – marketed for tissue repair
• CJC-1295 and Ipamorelin – marketed to boost growth hormone
• Sermorelin – a growth-hormone-releasing peptide once sold under an approved brand that was later discontinued for business reasons, not safety
• Epitalon and Semax – marketed for anti-aging and cognitive focus
• MOTS-c – marketed for metabolism and longevity
• GHK-Cu (copper peptide) – marketed for skin and wound healing peptide therapies

None of these are FDA-approved drugs. They have not completed the clinical trial process required for approval. Some have limited human research; others rely almost entirely on animal studies or anecdotal reports. That doesn’t automatically mean they’re dangerous, but it does mean their benefits and long-term safety haven’t been established the way an approved drug’s have.

The 2026 Regulatory Shake-Up: What’s Actually Changing

If you’ve seen recent headlines about peptides suddenly becoming “legal” again, here’s the accurate version of what happened.

In September 2023, the FDA placed 19 peptides, including BPC-157 and TB-500, into Category 2, which blocked compounding pharmacies from using them. In February 2026, HHS Secretary Robert F. Kennedy Jr. said publicly that he wanted many of these peptides moved back to Category 1. In April 2026, the FDA followed up by removing 12 of those peptides from Category 2, though that step alone didn’t add them to the approved compounding list. It simply reopened the door for formal review.

That review happened on July 23 and 24, 2026, when the FDA’s Pharmacy Compounding Advisory Committee met to evaluate seven peptides for the official compounding list. The committee voted, by a narrow 8-6 margin, to recommend six of them, including BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon. It voted against a seventh, emideltide (also known as DSIP).

Here’s the part that matters most for consumers: that vote was only a recommendation. The FDA still has to publish a proposed rule, take public comments, and issue a final rule before compounding pharmacies can legally use these peptides. Based on how past FDA rulemaking cycles have gone, that process can easily take a year or more. As of today, none of these peptides are FDA-approved drugs, and none are yet legally approved for routine compounding, whatever a clinic’s marketing page might claim.

What Does the Research Actually Show?

It helps to separate three different levels of evidence:

1. Established human evidence. FDA-approved peptides like semaglutide have been tested in large, controlled clinical trials involving thousands of patients. Their benefits and risks are documented in official prescribing information.
2. Early or limited human evidence. Some non-approved peptides have small human studies or trials for narrow uses, but not enough for full approval.
3. Animal, lab, or anecdotal evidence. Many popular “wellness” peptides, including BPC-157, rely mostly on rodent studies or user reports online. A mechanism that looks promising in a petri dish or a mouse doesn’t guarantee it works the same way, or safely, in people.

Marketing materials often blur these three categories together. A beginner-friendly rule of thumb: if a peptide’s benefits are described mainly through customer testimonials or “studies show” without a specific human trial cited, treat the claim as unproven rather than established.

Risks and Safety Considerations

Even FDA-approved peptides carry risks. GLP-1 drugs can cause nausea, gastrointestinal upset, and, rarely, more serious complications. Hormone-based peptides can affect fertility, mood, and bone health. That’s why they require a prescription and monitoring.

The risks look different with non-approved peptides sold online:

• No quality control. Products labeled “research use only” aren’t held to pharmaceutical manufacturing standards, so purity and dosage can vary between batches.
• No established human safety data. Long-term effects, especially with repeated injections, often aren’t known.
• Contamination risk. Products from unregulated suppliers have been found to contain incorrect concentrations or impurities.
• Legal gray area. Selling these substances for human use, even with a “not for human consumption” disclaimer, generally isn’t compliant with FDA rules.

Who Should Be Cautious

Anyone considering a peptide, approved or not, should be extra careful if they:

• Are pregnant or breastfeeding
• Have a history of cancer, since some peptides affect cell growth pathways
• Take other hormone-related medications
• Have kidney or liver conditions that affect how drugs are cleared from the body

A licensed doctor can check for interactions and confirm whether a peptide is appropriate, something no online seller can do.

Frequently Asked Questions

Is BPC-157 FDA-approved?
No. BPC-157 is not an FDA-approved drug. An FDA advisory committee recommended in July 2026 that it be allowed on the compounding list, but the FDA has not finalized that rule.

Are peptide injections legal in the US?
FDA-approved peptides are legal with a prescription. Peptides sold as “research chemicals” for human use generally fall outside FDA rules, even when labeled as not for human consumption.

Why are GLP-1 drugs like Ozempic considered peptides?
Semaglutide and tirzepatide are both short chains of amino acids that mimic natural gut hormones, which technically makes them peptides, even though they’re usually just called “weight-loss drugs” or “diabetes drugs.”

Can a doctor prescribe non-FDA-approved peptides?
In some cases, doctors can use compounding pharmacies for personalized treatments, but this depends on the peptide’s current FDA category and state pharmacy rules. It’s not the same as prescribing an approved drug.

Will more peptides get FDA approval in the future?
Yes, this is an active area of drug development. Several new peptide drugs reach the market most years, and regulatory reviews of compounding rules are ongoing.